Search

everythinglearnresearchcommunity

for

Search:↓

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

Finasteride and dutasteride reduce prostate cancer risk, but finasteride may increase higher-grade cancer risk.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

RPGRIP1L helps skin cells stick together by blocking PKCβII, which can prevent skin blistering like in pemphigus.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Gene expression differences in PFS patients suggest a potential organic cause for symptoms.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

Dutasteride may protect the brain in early Parkinson's disease.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Finasteride, a medication, is being re-evaluated for its effects and uses.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Phellodendri Cortex Extract may help treat benign prostatic hyperplasia.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Human skin cells contain Protease Nexin-1, and male hormones can decrease its levels, potentially affecting hair growth.

Finasteride effectively treats benign prostatic hyperplasia by reducing prostate size and improving urinary symptoms.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

SHPro® improved urinary symptoms and erectile function in men and is safe.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

α-Phellandrene may help prevent hair loss by increasing growth factors and cell growth in hair cells through a specific signaling pathway.

In 2005, men used finasteride mainly to treat an enlarged prostate.

DHT affects testicular development and regulates spermatogenesis in some fish.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

The research explains how a human enzyme binds and processes its substrate, which could relate to its role in biological functions and hair loss.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

Finasteride 1mg linked to diverse symptoms; other treatments improve erectile function in rats.